Metabolic syndrome, systemic inflammation and Framingham risk score are independent risk factors for reduced lung function in healthy Korean adults Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality Source: Eur Respir J 2010; 36: 1002-1006 Year: 2010
Ventilatory function as predictor of cardio-metabolic markers of cardiovascular disease: 10 year follow-up in young adults Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015
Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017
Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020 Year: 2021
Longitudinal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort. Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019
Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015
Lung function and respiratory symptoms as predictors of mortality: The HUNT study Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012
COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020
Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Risk factors of abnormal lung function in children and adolescents – data from the LEAD (Lung, hEart, sociAl, boDy) Study Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function Year: 2018
GOLD classification of COPD and incident lung cancer: findings from a cohort study Source: Eur Respir J 2004; 24: Suppl. 48, 269s Year: 2004
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020
Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD) Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020
CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014
Does genetic ancestry modify the relationship of smoking and lung function? The MESA lung study Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011
Risk of stroke in COPD: a matched cohort study Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017